ArticleBreast cancer research : BCR2024

In situ HER2 RNA expression as a predictor of pathologic complete response of HER2-positive breast cancer patients receiving neoadjuvant chemotherapy and anti-HER2 targeted treatment.

Huang-Chun Lien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.